Skip to main content
Premium Trial:

Request an Annual Quote

Ronen Tamir, Seymour Benzer, Sal Sanci, Paul Ford, James DeGeef, Don Listwin

Rosetta Genomics has appointed Ronen Tamir to be executive VP of marketing and communications, the company said last week. Tamir formerly was VP of investor relations for North America at Novartis and before that he was director of business intelligence and global product manager at Serono.

Genetics pioneer and California Institute of Technology researcher Seymour Benzer, who conducted early research in gene mapping, RNA, and who used phages to help verify James Watson and Francis Crick’s version of DNA structure, died last week at age 84, the Los Angeles Times reported.

GenoLogics has named Sal Sanci VP of products and Paul Ford VP of finance. Sanci formerly was VP of technology at Teligence and he was a VP at Pivotal Corporation, DocsFulcrum, and Meridian Technologies.
Ford was recently an executive director for the private equity firm PineRidge and he worked at KPMG as an advisory for mergers and acquisitions.
Also, GenoLogicsfounder and former VP of Product Management James DeGeef will take over the post of VP of market strategy.
The company also has named Don Listwin chairman of the company’s board of directors.

Filed under

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.